RxDoctor Payments Data

Kapildeo Lotun, MD

Interventional Cardiology · Tucson, AZNPI 1265510796

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $239,083 of the $365,367 with a category attached, or 65.4%. Medtronic accounts for 69.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $128,110 and has fallen 59.0% since, to $52,550 in 2025. Among interventional cardiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$365,367in general payments, 2019–2025

Across 836 payments — averaging $437.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$253K
  • Livanova USA, Inc.$35K
  • Edwards Lifesciences$34K
  • Boston Scientific$20K
  • Abiomed$15K
  • Abbott$3K
  • plus $4K from 21 others
$122,473in research payments, 2019–2025

Across 45 payments — averaging $2721.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$68K
  • Boston Scientific$36K
  • Abbott$15K
  • W. L. Gore & Associates, Inc.$4K
  • Abiomed$50

What the payments were for

  • Consulting fees$24,3447%
  • Speaking & faculty fees$239,08365%
  • Travel & lodging$77,00521%
  • Food & beverage$24,9117%
  • Education$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$365,367 in reported general payments places this provider in the 95th percentile of 223 interventional cardiology providers in Arizona.

See all interventional cardiology providers in Arizona

Medicare billing

Part B allowed, 2024
$198,951
Medicare patients
281
Services billed
1,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →